Literature DB >> 24736110

High-quality image acquisition by double exposure overlap in dental cone beam computed tomography.

Mark Plachtovics1, Peter Bujtar2, Katalin Nagy3, Maurice Mommaerts4.   

Abstract

OBJECTIVE: With a double exposure overlapping cone beam computed tomography (CBCT) scan technique, using CBCT acquisition radiation dose, the objective was to obtain apparent density similar to that of multidetector computed tomography (MDCT). STUDY
DESIGN: Factory quality-assurance phantom and water phantom were used for the evaluation of apparent density fidelity of iCAT scans in different modes. Each scan's apparent density was analyzed for identical regions using ImageJ, version 1.42q.
RESULTS: The iCAT Classic extended height acquisition with 4-cm central overlap and reconstruction of 2 groups of 300 projections per rotation for the water and quality-assurance CBCT phantoms resulted in improved apparent density fidelity. This apparent density accuracy was superior to that of iCAT scan at high resolution (600 projections during 1 rotation).
CONCLUSIONS: Using double exposure overlapping CBCT scans allows the analysis quality to be comparable with that of MDCT.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24736110     DOI: 10.1016/j.oooo.2014.02.024

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  3 in total

Review 1.  CBCT-based bone quality assessment: are Hounsfield units applicable?

Authors:  R Pauwels; R Jacobs; S R Singer; M Mupparapu
Journal:  Dentomaxillofac Radiol       Date:  2015       Impact factor: 2.419

2.  Comparison of the Hounsfield unit in CT scan with the gray level in cone-beam CT.

Authors:  Tahmineh Razi; Parya Emamverdizadeh; Nadia Nilavar; Sedigheh Razi
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2019-10-07

3.  Change in Image Quality According to the 3D Locations of a CBCT Phantom.

Authors:  Jae Joon Hwang; Hyok Park; Ho-Gul Jeong; Sang-Sun Han
Journal:  PLoS One       Date:  2016-04-19       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.